Clinical Trial Update: A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This is a Phase I trial assessing the safety and preliminary activity of combining cetuximab with gefitinib in patients with advanced or metastatic Non-Small Ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Gefitinib (Gefitinib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-Small-Cell Lung Carcinoma | Phase 1 | Status: COMPLETED